Notice: This company has been marked as potentially delisted and may not be actively trading. BioPlus Acquisition (BIOS) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Upstream Bio Pursues $100 Million IPO Plan With Encouraging Trial ResultsSeptember 25, 2024 | seekingalpha.comPayMate Plans to Acquire DigiAsia BiosSeptember 24, 2024 | marketwatch.comGigabyte details BIOS roll-out plan to neutralize Sinkclose vulnerability — eligible AMD CPUs should be patched by end of the monthAugust 24, 2024 | yahoo.comMadison's Mirus Bio to be acquired by MilliporeSigma for $600 millionMay 28, 2024 | bizjournals.comBiogen enters deal to acquire HI-Bio for $1.8bnMay 23, 2024 | msn.comBiogen’s Strategic Acquisition of HI-Bio and Diversification into Orphan Drug Market Prompt ‘Buy’ RatingMay 22, 2024 | markets.businessinsider.comBiogen to buy San Francisco startup developing a drug for kidney disease for $1.2BMay 22, 2024 | bizjournals.comBiogen to buy Peninsula startup developing a drug for kidney disease for $1.2 billionMay 22, 2024 | bizjournals.comBiogen buys California biotech for $1.15 billionMay 22, 2024 | msn.comVerde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions CompanyMay 14, 2024 | markets.businessinsider.comImugene and Kincell Bio Announce Strategic Manufacturing and Process Development PartnershipApril 16, 2024 | markets.businessinsider.comLouis G Lange's Net WorthApril 3, 2024 | benzinga.comWhy Intelligent Bio Solutions Stock Is Ripping HigherFebruary 9, 2024 | msn.comBioPlus Co Ltd (099430)January 22, 2024 | investing.comSPAC BioPlus, Avertix terminate merger; BioPlus to liquidateOctober 4, 2023 | msn.comAvertix, BIOS Acquisition Agree To Terminate Merger DealOctober 4, 2023 | markets.businessinsider.comAvertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationOctober 4, 2023 | finance.yahoo.comBioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateOctober 4, 2023 | finance.yahoo.comShort Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Declines By 36.0%BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 1,600 shares, a decline of 36.0% from the August 31st total of 2,500 shares. Based on an average daily trading volume, of 40,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company's stock are short sold.September 29, 2023 | marketbeat.comWeiss Asset Management LP Raises Stock Holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS)Weiss Asset Management LP raised its position in BioPlus Acquisition Corp. (NASDAQ:BIOS - Free Report) by 176.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 145,000 shares of the company's stock afterAugust 18, 2023 | marketbeat.comHeart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringAugust 16, 2023 | finance.yahoo.comAvertix Partners with Institute on Implantable Heart Attack Detection SystemAugust 16, 2023 | finance.yahoo.comAvertix Medical Welcomes Renown Cardiologist to Board of DirectorsJuly 20, 2023 | finance.yahoo.comRenown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsJuly 17, 2023 | finance.yahoo.comRadcliffe Capital Management L.P. Increases Stake in BioPlus Acquisition Corp. (NASDAQ:BIOS)Radcliffe Capital Management L.P. grew its position in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 38.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 555,355 shares of the company's stock after buying an additionalJune 15, 2023 | marketbeat.comAvertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoJune 13, 2023 | finance.yahoo.comRadcliffe Capital Management L.P. Boosts Stock Position in BioPlus Acquisition Corp. (NASDAQ:BIOS)Radcliffe Capital Management L.P. boosted its holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 38.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 555,355 shares of the company's stock afJune 9, 2023 | marketbeat.comBIOS BioPlus Acquisition Corp.May 26, 2023 | seekingalpha.comSPAC BIOS to merge with cardiac device maker AvertixMay 5, 2023 | msn.comAvertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationMay 3, 2023 | finance.yahoo.comBank of Montreal Can Trims Stock Holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS)Bank of Montreal Can lessened its stake in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 31.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 236,746 shares of the company's stockApril 24, 2023 | marketbeat.comCalamos Advisors LLC Buys Shares of 1,000,000 BioPlus Acquisition Corp. (NASDAQ:BIOS)Calamos Advisors LLC purchased a new stake in BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,000,000 shares of the company's stock, valued at approximately $10,April 7, 2023 | marketbeat.comParallax Volatility Advisers L.P. Makes New Investment in BioPlus Acquisition Corp. (NASDAQ:BIOS)Parallax Volatility Advisers L.P. bought a new position in BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 221,829 shares of the company's stock, valued at approximately $2,226,000. ParallaMarch 19, 2023 | marketbeat.comBioPlus Acquisition Corp - Ordinary Shares - Class AMarch 18, 2023 | money.usnews.comMarshall Wace LLP Purchases 120,000 Shares of BioPlus Acquisition Corp. (NASDAQ:BIOS)Marshall Wace LLP raised its position in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 31.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 502,350 shares of the company's stock after acquiring an adMarch 14, 2023 | marketbeat.com221,829 Shares in BioPlus Acquisition Corp. (NASDAQ:BIOS) Acquired by Parallax Volatility Advisers L.P.Parallax Volatility Advisers L.P. bought a new position in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 221,829 shares of the company's stock, valued at approximately $March 10, 2023 | marketbeat.comBioPlus Acquisition Corp. (NASDAQ:BIOS) Sees Significant Increase in Short InterestBioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,000 shares, an increase of 30.4% from the November 15th total of 2,300 shares. Based on an average daily volume of 51,600 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.December 14, 2022 | marketbeat.comBioPlus Acquisition Corp. (NASDAQ:BIOS) Sees Significant Growth in Short InterestBioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 2,300 shares, a growth of 21.1% from the October 31st total of 1,900 shares. Based on an average daily trading volume, of 50,700 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company's shares are sold short.December 1, 2022 | marketbeat.comShort Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Declines By 9.5%BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) was the target of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 1,900 shares, a drop of 9.5% from the October 15th total of 2,100 shares. Based on an average trading volume of 41,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.November 16, 2022 | marketbeat.comBioPlus Acquisition Corp. Cl ASeptember 23, 2022 | wsj.comBioPlus Acquisition Corp. (BIOS)September 20, 2022 | finance.yahoo.comBioPlus Acquisition Corp (BIOS)September 3, 2022 | investing.comBioPlus Acquisition CorpAugust 13, 2022 | reuters.comWhat Type Of Shareholders Own The Most Number of BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares?August 10, 2022 | finance.yahoo.com Get BioPlus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover BIOS Media Mentions By Week BIOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOS News Sentiment▼0.000.67▲Average Unclassified News Sentiment BIOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOS Articles This Week▼00▲BIOS Articles Average Week Get BioPlus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AACT News FSNB News CION News NETD News IPXX News RRAC News CDRO News ENPC News RENE News KVAC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPlus Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPlus Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
